Thousand Oaks, CA1 Active Studies

Neuroendocrine Tumors Clinical Trials in Thousand Oaks, CA

Find 1 actively recruiting neuroendocrine tumors clinical trials in Thousand Oaks, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
600
Enrolling

Recruiting Neuroendocrine Tumors Studies in Thousand Oaks

About Neuroendocrine Tumors Clinical Trials in Thousand Oaks

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 1 neuroendocrine tumors clinical trials recruiting participants in Thousand Oaks, CA. These studies are seeking a combined 600 participants. Research is being sponsored by Pelage Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Thousand Oaks — FAQ

Are there neuroendocrine tumors clinical trials in Thousand Oaks?

Yes, there are 1 neuroendocrine tumors clinical trials currently recruiting in Thousand Oaks, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Thousand Oaks?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Thousand Oaks research site will contact you about next steps.

Are clinical trials in Thousand Oaks free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Thousand Oaks studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 1 active trials in Thousand Oaks are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated October 3, 2026 from ClinicalTrials.gov